{
    "2019-12-13": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Pharma Stock Roundup: MRK, SNY to Buy Cancer Firms, LLY Starts New Lung Cancer Study",
                "features": {
                    "keywords": [
                        "MRK",
                        "SNY",
                        "Cancer Firms",
                        "LLY",
                        "Lung Cancer Study"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "Boehringer Ingelheim and Lilly provide update on Jardiance® phase III exercise ability studies in chronic heart failure",
                "features": {
                    "keywords": [
                        "Boehringer Ingelheim",
                        "Lilly",
                        "Jardiance",
                        "phase III",
                        "chronic heart failure"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "What to Do with Karuna Stock After It Soared and Then Plunged",
                "features": {
                    "keywords": [
                        "Karuna",
                        "Soared",
                        "Plunged"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "CHMP Issues Positive Opinion to Expand CYRAMZA® (ramucirumab) Label to Include Results from RELAY Study in Patients with Metastatic EGFR-Mutated Non-Small Cell Lung Cancer",
                "features": {
                    "keywords": [
                        "CHMP",
                        "CYRAMZA",
                        "ramucirumab",
                        "RELAY Study",
                        "EGFR-Mutated",
                        "Non-Small Cell Lung Cancer"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "oncology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}